Family Office Of America (FOFA) Change in Accured Expenses (2021 - 2026)
Family Office Of America's (FOFA) quarterly Change in Accured Expenses came in at $735.0 in Q1 2026, up 228.12% year-on-year from $224.0 in Q1 2025, and down 93.08% quarter-over-quarter from $10625.0 in Q3 2025.
Family Office Of America (FOFA) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Family Office Of America has disclosed Change in Accured Expenses across 6 years of filings, most recently posting $735.0 for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $735.0, up 228.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $1039.0 (down 92.0% YoY), and the FY2025 annual result was $528.0, down 96.9% from the prior year.
- Change in Accured Expenses came in at $735.0 for Q1 2026 at Family Office Of America, down from $10625.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $20656.0 in Q4 2022 to a low of -$17826.0 in Q1 2023.
- The 5-year median for Change in Accured Expenses is $1454.5 (2024), against an average of -$117.21.
- Across the five-year window, Change in Accured Expenses sank 574.75% in 2025 and soared 228.12% in 2026, its largest moves.
- Family Office Of America's Change in Accured Expenses stood at $20656.0 in 2022, then sank by 152.47% to -$10838.0 in 2023, then jumped by 137.53% to $4068.0 in 2024, then jumped by 161.18% to $10625.0 in 2025, then slumped by 93.08% to $735.0 in 2026.
- The last three Change in Accured Expenses figures came in at $735.0 (Q1 2026), $10625.0 (Q3 2025), and -$10321.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | 735.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 735.00 |
| Mar 31, 2026 | 735.00 |
| Sep 30, 2025 | 10,625.00 |
| Sep 30, 2025 | 10,625.00 |
| Jun 30, 2025 | -10,321.00 |
| Jun 30, 2025 | -10,321.00 |
| Mar 31, 2025 | 224.00 |
| Mar 31, 2025 | 224.00 |
| Dec 31, 2024 | 4,068.00 |
| Dec 31, 2024 | 4,068.00 |
| Sep 30, 2024 | 6,517.00 |
| Sep 30, 2024 | 6,517.00 |
| Jun 30, 2024 | 2,174.00 |
| Jun 30, 2024 | 2,174.00 |
| Mar 31, 2024 | 4,300.00 |
| Mar 31, 2024 | 4,300.00 |
| Dec 31, 2023 | -10,838.00 |
| Dec 31, 2023 | -10,838.00 |
| Jun 30, 2023 | -13,366.00 |
| Jun 30, 2023 | -13,366.00 |